Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease - RAVE

Description:

The goal of the Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease (RAVE) trial was to evaluate whether treatment with adenovirus encoding vascular endothelial growth factor (AdVEGF121) increased peak walking time in patients with intermittent claudication (IC) due to infra-inguinal atherosclerosis.